Mittie Doyle
Chief Medical Officer; Director · 14 filings · Latest: Aug 10, 2026
Avalo Therapeutics, Inc.
Cullinan Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AVTX | Mittie Doyle | Chief Medical Officer | Aug 10, 2026 | Sale | $20.00 | 679 | $13.6K | 51,776 | |
AVTX | Mittie Doyle | Chief Medical Officer | Aug 10, 2026 | Option Exercise | $8.04 | 679 | $5.5K | 52,455 | |
AVTX | MITTIE DOYLE | — | Aug 10, 2026 | Proposed Sale | $18.32 | 679 | $12.4K | — | |
AVTX | Mittie Doyle | Chief Medical Officer | Jul 27, 2026 | Sale | $20.00 | 1,000 | $20.0K | 51,776 | |
AVTX | Mittie Doyle | Chief Medical Officer | Jul 27, 2026 | Option Exercise | $12.65 | 1,000 | $12.7K | 52,776 | |
AVTX | Mittie Doyle | Chief Medical Officer | Jun 30, 2026 | Sale | $20.00 | 4,654 | $93.1K | 51,776 | |
AVTX | Mittie Doyle | Chief Medical Officer | Jun 30, 2026 | Option Exercise | $10.89 | 4,654 | $50.7K | 56,430 | |
AVTX | Mittie Doyle | Chief Medical Officer | Jun 23, 2026 | Sale | $18.00 | 1,450 | $26.1K | 51,776 | |
AVTX | Mittie Doyle | Chief Medical Officer | Jun 23, 2026 | Option Exercise | $8.04 | 1,450 | $11.7K | 53,226 | |
AVTX | Mittie Doyle | Chief Medical Officer | May 28, 2026 | Sale | $16.00 | 679 | $10.9K | 47,122 | |
AVTX | Mittie Doyle | Chief Medical Officer | May 28, 2026 | Option Exercise | $8.04 | 679 | $5.5K | 47,801 | |
AVTX | Mittie Doyle | Chief Medical Officer | May 15, 2026 | Sale | $18.76 | 3,000 | $56.3K | 3,622 | |
AVTX | Mittie Doyle | Chief Medical Officer | May 15, 2026 | Option Exercise | $12.65 | 3,000 | $38.0K | 6,622 | |
AVTX | Mittie Doyle | Chief Medical Officer | May 6, 2026 | Sale | $20.68 | 106,555 | $2.2M | 3,622 | |
AVTX | Mittie Doyle | Chief Medical Officer | May 6, 2026 | Option Exercise | $11.41 | 106,555 | $1.2M | 110,177 | |
AVTX | Mittie Doyle | Chief Medical Officer | May 5, 2026 | Sale | $16.00 | 1,679 | $26.9K | 3,622 | |
AVTX | Mittie Doyle | Chief Medical Officer | May 5, 2026 | Option Exercise | $10.79 | 1,679 | $18.1K | 5,301 | |
AVTX | MITTIE DOYLE | — | May 6, 2026 | Proposed Sale | $16.26 | 54,508 | $886.3K | — | |
AVTX | Mittie Doyle | Chief Medical Officer | Apr 6, 2026 | Sale | $18.01 | 3,970 | $71.5K | 3,622 | |
AVTX | Mittie Doyle | Chief Medical Officer | Apr 6, 2026 | Option Exercise | $12.65 | 3,970 | $50.2K | 7,592 |
Page 1 of 2
Next →